Oncology Institute, Inc. (TOI) Change in Account Payables (2020 - 2026)

Oncology Institute (TOI) has 7 years of Change in Account Payables data on file, last reported at $4.6 million in Q1 2026.

• Quarterly Change in Account Payables fell 8.82% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 million (up 142.48% YoY) and the FY2025 annual result came in at $19.6 million, up 113.11% from the prior year.
• Change in Account Payables declined to $4.6 million in Q1 2026, from $7.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.7 million in Q4 2025 to a low of -$5.5 million in Q2 2024.
• A 5-year average of $1.9 million and a median of $1.2 million in 2023 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables slumped 725.11% — and 2024, when it surged 3508.57%.
• Tracing TOI's Change in Account Payables over 5 years: stood at -$1.8 million in 2022, then jumped by 161.47% to $1.1 million in 2023, then plunged by 32.57% to $739000.0 in 2024, then soared by 943.17% to $7.7 million in 2025, then sank by 40.19% to $4.6 million in 2026.
• The last three Change in Account Payables figures came in at $4.6 million (Q1 2026), $7.7 million (Q4 2025), and $439000.0 (Q3 2025), per Business Quant data.